CDD3506
Product Specifications
UNSPSC Description
CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
Target Antigen
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/CDD3506.html
Purity
98.03
Solubility
DMSO : 19 mg/mL (ultrasonic)
Smiles
NC1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
Molecular Weight
325.41
References & Citations
[1]Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-100902/CDD3506-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-100902/CDD3506-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
197913-15-8
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Staphylococcus aureus ATP synthase subunit c (atpE), partial
